Immune to Cancer: The CRI Blog
-
How Targeting a Rare Blood Cancer Complication and Bacteria in Colorectal Cancer Can Bolster Immunotherapy Outcomes
Immunotherapy triggers the body’s immune system to effectively and precisely respond to cancer. However, immunotherapy is not… -
Supercharging T Cells to Fight Cancer: A Revolutionary Discovery
In the battle against cancer, our immune system’s T cells are frontline soldiers, designed to seek out… -
Can Table Salt Supercharge Your Immune System to Fight Cancer?
The Cancer Research Institute (CRI) is excited to share the latest study from CRI Lloyd J. Old… -
Tecelra® Receives FDA Approval: A New Milestone in Cancer Treatment
On August 2, 2024, the U.S Food and Drug Administration (FDA) approved Tecelra® (afamitresgene autoleucel), a gene… -
How Focused Ultrasound and Immunotherapy Could Transform Cancer Treatment
Recent advancements in cancer treatment are reshaping patient care in multiple ways. Focused ultrasound and cancer immunotherapy… -
New Insights on CAR-T Design: Paving the Way for Broader Cancer Applications
The Cancer Research Institute (CRI) is excited to share the latest study from CRI Lloyd J. Old… -
ASCO 2022 Recap: Cancer Immunotherapy Updates
Since the first FDA approval in 2011 to treat cancer patients with checkpoint immunotherapy, doctors have sought… -
AACR 2022 Recap: T Cells Still On Top, But Make Room for Myeloid Cells
At the 2022 AACR annual meeting, CRI scientists highlighted a wide scope of cancer immunology advances, and…
-
Novel CAR Immunotherapies for Pancreatic Cancer with Dr. Ryan Alexander
CRI Fellow Ryan Alexander is developing new cellular immunotherapies for pancreatic cancer.